Celastrol in cancer therapy: Recent developments, challenges and prospects

HY Lim, PS Ong, L Wang, A Goel, L Ding, ALA Wong… - Cancer Letters, 2021 - Elsevier
Cancer is one of the world's biggest healthcare burdens and despite the current
advancements made in treatment plans, the outcomes for oncology patients have yet to …

Hollow Nanomaterials in Advanced Drug Delivery Systems: From Single‐to Multiple Shells

Z Li, K Xu, L Qin, D Zhao, N Yang, D Wang… - Advanced …, 2023 - Wiley Online Library
Hollow‐structured nanomaterials (HSNMs) have attracted increased interest in biomedical
fields, owing to their excellent potential as drug delivery systems (DDSs) for clinical …

Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1

H Xu, H Zhao, C Ding, D Jiang, Z Zhao, Y Li… - … and Targeted Therapy, 2023 - nature.com
As a terpenoids natural product isolated from the plant Thunder God Vine, Celastrol is
widely studied for its pharmacological activities, including anti-tumor activities. The clinical …

Advanced computational methodologies used in the discovery of new natural anticancer compounds

VP Chavda, YN Ertas, V Walhekar, D Modh… - Frontiers in …, 2021 - frontiersin.org
Natural chemical compounds have been widely investigated for their programmed necrosis
causing characteristics. One of the conventional methods for screening such compounds is …

Celastrol in metabolic diseases: Progress and application prospects

S Xu, Y Feng, W He, W Xu, W Xu, H Yang, X Li - Pharmacological research, 2021 - Elsevier
Metabolic diseases are becoming increasingly common in modern society. Therefore, it is
essential to develop effective drugs or new treatments for metabolic diseases. As an active …

Tumor-targeted exosomes for delivery of anticancer drugs

R Raguraman, D Bhavsar, D Kim, X Ren, V Sikavitsas… - Cancer letters, 2023 - Elsevier
Exosomes are small phospholipid bilayer vesicles that are naturally produced by all living
cells, both prokaryotes and eukaryotes. The exosomes due to their unique size, reduced …

[HTML][HTML] Engineering neoantigen vaccines to improve cancer personalized immunotherapy

Z Liu, J Lv, Q Dang, L Liu, S Weng, L Wang… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
Immunotherapy treatments harnessing the immune system herald a new era of personalized
medicine, offering considerable benefits for cancer patients. Over the past years, tumor …

Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down …

M Youns, M Askoura, HA Abbas, GH Attia… - OncoTargets and …, 2021 - Taylor & Francis
Background Pancreatic cancer is one of the most serious and lethal human cancers with a
snowballing incidence around the world. The natural product celastrol has also been widely …

Oxidative stress inducers in Cancer therapy: preclinical and clinical evidence

ZN Nizami, HE Aburawi, A Semlali, K Muhammad… - Antioxidants, 2023 - mdpi.com
Reactive oxygen species (ROS) are metabolic byproducts that regulate various cellular
processes. However, at high levels, ROS induce oxidative stress, which in turn can trigger …

Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors

YH Dinakar, H Kumar, SL Mudavath, R Jain, R Ajmeer… - Life Sciences, 2022 - Elsevier
Introduction Breast cancer (BC) accounts for the majority of cancers among the female
population. Anomalous activation of various signaling pathways has become an issue of …